C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/08 (2006.01) A61K 31/55 (2006.01) A61K 31/695 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2050284
The invention relates to methods for the treatment or prevention of neuronal loss in ischemia, hypoxia, hypoglycemia, brain and spinal cord trauma as well as for treatment of Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's Syndrome by administering a pharmaceutical composition comprising an effective amount of 10,5-(iminomethano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (IDDC) or derivatives thereof to an animal.
L'invention concerne des procédés pour le traitement ou la prévention de la perte ou dégradation de neurones dans l'ischémie, l'hypoxie, l'hypoglycémie, les traumatismes du cerveau et du cordon médullaire ainsi que pour le traitement de la maladie d'Alzheimer, la schlérose latérale amiotrophique, la maladie de Huntington et le syndrome de Down par administration à un animal d'une composition pharmaceutique comprenant une quantité efficace de 10,5-(iminométhano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptène (IDDC) ou des dérivés de ce composé.
Barmettler Peter
Keana John F. W.
Weber Eckard
Acting For And On Behalf Of The Oregon Health Sciences Univer State Of Oregon Acting By And Through The Oregon State Board Of
Gowling Lafleur Henderson Llp
LandOfFree
Pcp receptor ligands and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pcp receptor ligands and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pcp receptor ligands and the use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1598026